A New Colon Cancer Project Worth €25.8 million – TopNews New Zealand
By Dr. Matthew Watson
 TopNews New Zealand | A New Colon Cancer Project Worth €25.8 million TopNews New Zealand A new five-year project to develop and evaluate new biomarkers for colon cancer has been launched by OncoTrack and managed by Bayer and the Max Planck Institute for Molecular Genetics. The project will aim at developing personalized medicine for the ... OncoTrack Consortium Launches $35.6M Colon Cancer InitiativeGenomeWeb Daily News OncoTrack: A new International consortium launches project in the area of ...The FINANCIAL Bayer leads massive industry/academia consortium for colon cancer researchThe Pharma Letter Zenopa all 7 news articles » |
Uncategorized
Comments Off on A New Colon Cancer Project Worth €25.8 million – TopNews New Zealand |
March 13th, 2011
This author published 5912 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research